Table of Contents 1 Study Coverage 1.1 Diabetes Drugs Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Diabetes Drugs Market Size Growth Rate by Product 1.4.2 Sulphonylureas 1.4.3 Biguanides 1.4.4 Meglitinides 1.4.5 Thiazolidinediones 1.4.6 Alpha-glucosidase Inhibitors 1.4.7 DPP-4 Inhibitors 1.4.8 SGLT-2 Inhibitors 1.5 Market by End User 1.5.1 Global Diabetes Drugs Market Size Growth Rate by End User 1.5.2 Application I 1.5.3 Application II 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Diabetes Drugs Market Size 2.1.1 Global Diabetes Drugs Revenue 2014-2025 2.1.2 Global Diabetes Drugs Sales 2014-2025 2.2 Diabetes Drugs Growth Rate by Regions 2.2.1 Global Diabetes Drugs Sales by Regions 2.2.2 Global Diabetes Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Diabetes Drugs Sales by Manufacturers 3.1.1 Diabetes Drugs Sales by Manufacturers 3.1.2 Diabetes Drugs Sales Market Share by Manufacturers 3.1.3 Global Diabetes Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Diabetes Drugs Revenue by Manufacturers 3.2.1 Diabetes Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Diabetes Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Diabetes Drugs Price by Manufacturers 3.4 Diabetes Drugs Manufacturing Base Distribution, Product Types 3.4.1 Diabetes Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Diabetes Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Diabetes Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Diabetes Drugs Sales by Product 4.2 Global Diabetes Drugs Revenue by Product 4.3 Diabetes Drugs Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Diabetes Drugs Breakdown Data by End User 6 North America 6.1 North America Diabetes Drugs by Countries 6.1.1 North America Diabetes Drugs Sales by Countries 6.1.2 North America Diabetes Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Diabetes Drugs by Product 6.3 North America Diabetes Drugs by End User 7 Europe 7.1 Europe Diabetes Drugs by Countries 7.1.1 Europe Diabetes Drugs Sales by Countries 7.1.2 Europe Diabetes Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Diabetes Drugs by Product 7.3 Europe Diabetes Drugs by End User 8 Asia Pacific 8.1 Asia Pacific Diabetes Drugs by Countries 8.1.1 Asia Pacific Diabetes Drugs Sales by Countries 8.1.2 Asia Pacific Diabetes Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Diabetes Drugs by Product 8.3 Asia Pacific Diabetes Drugs by End User 9 Central & South America 9.1 Central & South America Diabetes Drugs by Countries 9.1.1 Central & South America Diabetes Drugs Sales by Countries 9.1.2 Central & South America Diabetes Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Diabetes Drugs by Product 9.3 Central & South America Diabetes Drugs by End User 10 Middle East and Africa 10.1 Middle East and Africa Diabetes Drugs by Countries 10.1.1 Middle East and Africa Diabetes Drugs Sales by Countries 10.1.2 Middle East and Africa Diabetes Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Diabetes Drugs by Product 10.3 Middle East and Africa Diabetes Drugs by End User 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Company Business Overview 11.1.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Sanofi Diabetes Drugs Products Offered 11.1.5 Sanofi Recent Development 11.2 Novo Nordisk 11.2.1 Novo Nordisk Company Details 11.2.2 Company Business Overview 11.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Novo Nordisk Diabetes Drugs Products Offered 11.2.5 Novo Nordisk Recent Development 11.3 MSD 11.3.1 MSD Company Details 11.3.2 Company Business Overview 11.3.3 MSD Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 MSD Diabetes Drugs Products Offered 11.3.5 MSD Recent Development 11.4 Astrazeneca 11.4.1 Astrazeneca Company Details 11.4.2 Company Business Overview 11.4.3 Astrazeneca Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Astrazeneca Diabetes Drugs Products Offered 11.4.5 Astrazeneca Recent Development 11.5 Takeda 11.5.1 Takeda Company Details 11.5.2 Company Business Overview 11.5.3 Takeda Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Takeda Diabetes Drugs Products Offered 11.5.5 Takeda Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Company Business Overview 11.6.3 Novartis Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Novartis Diabetes Drugs Products Offered 11.6.5 Novartis Recent Development 11.7 North China Pharmaceutical Group Corporation 11.7.1 North China Pharmaceutical Group Corporation Company Details 11.7.2 Company Business Overview 11.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 North China Pharmaceutical Group Corporation Diabetes Drugs Products Offered 11.7.5 North China Pharmaceutical Group Corporation Recent Development 11.8 Huadong Medicine 11.8.1 Huadong Medicine Company Details 11.8.2 Company Business Overview 11.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Huadong Medicine Diabetes Drugs Products Offered 11.8.5 Huadong Medicine Recent Development 11.9 Dongbao Pharmaceutical 11.9.1 Dongbao Pharmaceutical Company Details 11.9.2 Company Business Overview 11.9.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Dongbao Pharmaceutical Diabetes Drugs Products Offered 11.9.5 Dongbao Pharmaceutical Recent Development 11.10 Hisun Pharmacy 11.10.1 Hisun Pharmacy Company Details 11.10.2 Company Business Overview 11.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Hisun Pharmacy Diabetes Drugs Products Offered 11.10.5 Hisun Pharmacy Recent Development 11.11 KELUN 11.12 Ginwa 11.13 Tianan Pharmaceutical 11.14 Jumpcan Pharmacy 11.15 Guangzhou Baiyun Mountain 11.16 SHIJIAZHUANG YILING PHARMACEUTICAL 11.17 Wanbang Biopharmaceuticals 11.18 Gan & Lee 11.19 Taloph 12 Future Forecast 12.1 Diabetes Drugs Market Forecast by Regions 12.1.1 Global Diabetes Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Diabetes Drugs Revenue Forecast by Regions 2019-2025 12.2 Diabetes Drugs Market Forecast by Product 12.2.1 Global Diabetes Drugs Sales Forecast by Product 2019-2025 12.2.2 Global Diabetes Drugs Revenue Forecast by Product 2019-2025 12.3 Diabetes Drugs Market Forecast by End User 12.4 North America Diabetes Drugs Forecast 12.5 Europe Diabetes Drugs Forecast 12.6 Asia Pacific Diabetes Drugs Forecast 12.7 Central & South America Diabetes Drugs Forecast 12.8 Middle East and Africa Diabetes Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Diabetes Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Diabetes Drugs Product Picture Table Diabetes Drugs Market Segments Table Key Manufacturers Diabetes Drugs Covered Table Global Diabetes Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Diabetes Drugs Sales Market Share by Product 2014-2025 Figure Sulphonylureas Product Picture Table Major Manufacturers of Sulphonylureas Figure Biguanides Product Picture Table Major Manufacturers of Biguanides Figure Meglitinides Product Picture Table Major Manufacturers of Meglitinides Figure Thiazolidinediones Product Picture Table Major Manufacturers of Thiazolidinediones Figure Alpha-glucosidase Inhibitors Product Picture Table Major Manufacturers of Alpha-glucosidase Inhibitors Figure DPP-4 Inhibitors Product Picture Table Major Manufacturers of DPP-4 Inhibitors Figure SGLT-2 Inhibitors Product Picture Table Major Manufacturers of SGLT-2 Inhibitors Table Global Diabetes Drugs Market Size Growth Rate by End User 2019-2025 (K Units) Figure Application I Figure Application II Figure Diabetes Drugs Report Years Considered Figure Global Diabetes Drugs Market Size 2014-2025 (Million US$) Figure Global Diabetes Drugs Sales 2014-2025 (K Units) Table Global Diabetes Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Diabetes Drugs Sales by Regions 2014-2019 (K Units) Table Global Diabetes Drugs Sales Market Share by Regions 2014-2019 Figure Global Diabetes Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Diabetes Drugs Sales Market Share by Regions Table Global Diabetes Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Diabetes Drugs Revenue Market Share by Regions 2014-2019 Figure Global Diabetes Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Diabetes Drugs Revenue Market Share by Regions Table Global Diabetes Drugs Sales by Manufacturers (2014-2019) (K Units) Table Global Diabetes Drugs Sales Share by Manufacturers (2014-2019) Figure Global Diabetes Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Diabetes Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Diabetes Drugs Revenue Share by Manufacturers (2014-2019) Figure Diabetes Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Diabetes Drugs Price (2014-2019) (USD/Unit) Table Diabetes Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Diabetes Drugs Product Type Table Date of International Manufacturers Enter into Diabetes Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Diabetes Drugs Sales by Product (2014-2019) (K Units) Table Global Diabetes Drugs Sales Share by Product (2014-2019) Figure Global Diabetes Drugs Sales Market Share by Product (2014-2019) Figure Global Diabetes Drugs Sales Market Share by Product in 2018 Table Global Diabetes Drugs Revenue by Product (2014-2019) (Million US$) Table Global Diabetes Drugs Revenue Share by Product (2014-2019) Figure Global Diabetes Drugs Revenue Market Share by Product (2014-2019) Figure Global Diabetes Drugs Revenue Market Share by Product in 2018 Table Diabetes Drugs Price by Product 2014-2019 (USD/Unit) Table Global Diabetes Drugs Sales by End User (2014-2019) (K Units) Table Global Diabetes Drugs Sales Share by End User (2014-2019) Figure Global Sales Diabetes Drugs Market Share by End User (2014-2019) Figure Global Sales Diabetes Drugs Market Share by End User in 2018 Figure North America Diabetes Drugs Sales Growth Rate 2014-2019 (K Units) Figure North America Diabetes Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Diabetes Drugs Sales by Countries (2014-2019) (K Units) Table North America Diabetes Drugs Sales Market Share by Countries (2014-2019) Figure 2018 North America Diabetes Drugs Sales Market Share by Countries Table North America Diabetes Drugs Revenue by Countries (2014-2019) (Million US$) Table North America Diabetes Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 North America Diabetes Drugs Revenue Market Share by Countries Figure United States Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure United States Diabetes Drugs Revenue Growth Rate (2014-2019) (K Units) Figure Canada Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Canada Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Mexico Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Diabetes Drugs Sales by Product (2014-2019) (K Units) Table North America Diabetes Drugs Sales Market Share by Product (2014-2019) Figure 2018 North America Diabetes Drugs Market Share by Product Table North America Diabetes Drugs Sales by End User (2014-2019) (K Units) Table North America Diabetes Drugs Sales Market Share by End User (2014-2019) Figure 2018 North America Diabetes Drugs Market Share by End User Figure Europe Diabetes Drugs Sales Growth Rate 2014-2019 (K Units) Figure Europe Diabetes Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Diabetes Drugs Sales by Countries (2014-2019) (K Units) Table Europe Diabetes Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Europe Diabetes Drugs Sales Market Share by Countries Table Europe Diabetes Drugs Revenue by Countries (2014-2019) (Million US$) Table Europe Diabetes Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Diabetes Drugs Revenue Market Share by Countries Figure Germany Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Germany Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure France Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure UK Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Italy Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Russia Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Diabetes Drugs Sales by Product (2014-2019) (K Units) Table Europe Diabetes Drugs Sales Market Share by Product (2014-2019) Figure 2018 Europe Diabetes Drugs Market Share by Product Table Europe Diabetes Drugs Sales by End User (2014-2019) (K Units) Table Europe Diabetes Drugs Sales Market Share by End User (2014-2019) Figure 2018 Europe Diabetes Drugs Market Share by End User Figure Asia Pacific Diabetes Drugs Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Diabetes Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Diabetes Drugs Sales by Countries (2014-2019) (K Units) Table Asia Pacific Diabetes Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Diabetes Drugs Sales Market Share by Countries Table Asia Pacific Diabetes Drugs Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Diabetes Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Diabetes Drugs Revenue Market Share by Countries Figure China Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure China Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Japan Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Korea Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure India Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Australia Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Philippines Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Thailand Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Singapore Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Diabetes Drugs Sales by Product (2014-2019) (K Units) Table Asia Pacific Diabetes Drugs Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Diabetes Drugs Market Share by Product Table Asia Pacific Diabetes Drugs Sales by End User (2014-2019) (K Units) Table Asia Pacific Diabetes Drugs Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Diabetes Drugs Market Share by End User Figure Central & South America Diabetes Drugs Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Diabetes Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Diabetes Drugs Sales by Countries (2014-2019) (K Units) Table Central & South America Diabetes Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Diabetes Drugs Sales Market Share by Countries Table Central & South America Diabetes Drugs Revenue by Countries (2014-2019) (Million US$) Table Central & South America Diabetes Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Diabetes Drugs Revenue Market Share by Countries Figure Brazil Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Brazil Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Argentina Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Diabetes Drugs Sales by Product (2014-2019) (K Units) Table Central & South America Diabetes Drugs Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Diabetes Drugs Market Share by Product Table Central & South America Diabetes Drugs Sales by End User (2014-2019) (K Units) Table Central & South America Diabetes Drugs Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Diabetes Drugs Market Share by End User Figure Middle East and Africa Diabetes Drugs Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Diabetes Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Diabetes Drugs Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Diabetes Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Diabetes Drugs Sales Market Share by Countries Table Middle East and Africa Diabetes Drugs Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Diabetes Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Diabetes Drugs Revenue Market Share by Countries Figure GCC Countries Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Turkey Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure Egypt Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Diabetes Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Africa Diabetes Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Diabetes Drugs Sales by Product (2014-2019) (K Units) Table Middle East and Africa Diabetes Drugs Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Diabetes Drugs Market Share by Product Table Middle East and Africa Diabetes Drugs Sales by End User (2014-2019) (K Units) Table Middle East and Africa Diabetes Drugs Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Diabetes Drugs Market Share by End User Table Sanofi Company Details Table Sanofi Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Recent Development Table Novo Nordisk Company Details Table Novo Nordisk Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novo Nordisk Recent Development Table MSD Company Details Table MSD Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table MSD Recent Development Table Astrazeneca Company Details Table Astrazeneca Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Astrazeneca Recent Development Table Takeda Company Details Table Takeda Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Takeda Recent Development Table Novartis Company Details Table Novartis Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table North China Pharmaceutical Group Corporation Company Details Table North China Pharmaceutical Group Corporation Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table North China Pharmaceutical Group Corporation Recent Development Table Huadong Medicine Company Details Table Huadong Medicine Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Huadong Medicine Recent Development Table Dongbao Pharmaceutical Company Details Table Dongbao Pharmaceutical Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dongbao Pharmaceutical Recent Development Table Hisun Pharmacy Company Details Table Hisun Pharmacy Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Hisun Pharmacy Recent Development Table KELUN Company Details Table Ginwa Company Details Table Tianan Pharmaceutical Company Details Table Jumpcan Pharmacy Company Details Table Guangzhou Baiyun Mountain Company Details Table SHIJIAZHUANG YILING PHARMACEUTICAL Company Details Table Wanbang Biopharmaceuticals Company Details Table Gan & Lee Company Details Table Taloph Company Details Table Global Diabetes Drugs Sales Forecast by Regions 2019-2025 (K Units) Table Global Diabetes Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Diabetes Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Diabetes Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Diabetes Drugs Sales Forecast by Product 2019-2025 (K Units) Table Global Diabetes Drugs Sales Market Share Forecast by Product 2019-2025 Table Global Diabetes Drugs Revenue Forecast by Product 2019-2025 (Million US$) Table Global Diabetes Drugs Revenue Market Share Forecast by Product 2019-2025 Table Global Diabetes Drugs Sales Forecast by End User 2019-2025 (K Units) Table Global Diabetes Drugs Sales Market Share Forecast by End User 2019-2025 Figure North America Diabetes Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Diabetes Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Diabetes Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Diabetes Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Diabetes Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Diabetes Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Diabetes Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Diabetes Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Diabetes Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Diabetes Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Diabetes Drugs Value Chain Table Diabetes Drugs Customers List Table Diabetes Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Novo Nordisk MSD Astrazeneca Takeda Novartis North China Pharmaceutical Group Corporation Huadong Medicine Dongbao Pharmaceutical Hisun Pharmacy KELUN Ginwa Tianan Pharmaceutical Jumpcan Pharmacy Guangzhou Baiyun Mountain SHIJIAZHUANG YILING PHARMACEUTICAL Wanbang Biopharmaceuticals Gan & Lee Taloph